Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019. Yet the stock has since plummeted 61% from its peak value. Despite ...

Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results from a candidate that could be a game changer in this area of high demand.

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. When should six drugs count ...

Elizabeth Pennell alleges that Novo Nordisk A/S, the drug’s manufacturer, should have been aware of the potential risk of blindness associated with the medication. Pennell, who was using Ozempic to ...

Guggenheim downgraded Novo Nordisk (NVO) to Neutral from Buy. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

Novo Nordisk logo above the entrance to their offices in Hillerod 35,180 people played the daily Crossword recently. Can you solve it faster than others?35,180 people played the daily Crossword ...

Michael Field, chief EMEA equity strategist at Morningstar, discusses European stocks amid tariff uncertainty. Despite a court order, White House bars AP from Oval Office event Actors Who Refused ...

No­vo Nordisk is pour­ing 6.4 bil­lion Brazil­ian reais ($1.05 bil­lion) in­to a fac­to­ry in Brazil, to ramp up pro­duc­tion of its block­buster GLP-1 drugs af­ter … ...

Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the company ramps up efforts to increase production of its flagship glucagon-like peptide 1 receptor ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...